Analisis Efektivitas Biaya Penggunaan Antidiabetik Metformin Dan Glimepirid Pada Pasien Diabetes Melitus Tipe II Di RSUD Caruban Madiun Tahun 2016

Rahmadhani, Mega Kurnia Laily and , Mariska Sri Harlianti, M.Sc., Apt. (2017) Analisis Efektivitas Biaya Penggunaan Antidiabetik Metformin Dan Glimepirid Pada Pasien Diabetes Melitus Tipe II Di RSUD Caruban Madiun Tahun 2016. Skripsi thesis, Universitas Muhammadiyah Surakarta.

	PDF (Naskah Publikasi) NASKAH PUBLIKASI.pdf Download (633kB)
	PDF (Halaman Depan) HALAMAN DEPAN.pdf Download (6MB)
	PDF (Bab I) BAB I.pdf Download (414kB)
	PDF (Bab II) BAB II.pdf Restricted to Repository staff only Download (277kB) | Request a copy
	PDF (Bab III) BAB III.pdf Restricted to Repository staff only Download (140kB) | Request a copy
	PDF (Bab IV) BAB IV.pdf Restricted to Repository staff only Download (84kB) | Request a copy
	PDF (Daftar Pustaka) DAFTAR PUSTAKA.pdf Download (160kB)
	PDF (Lampiran) LAMPIRAN.pdf Restricted to Repository staff only Download (610kB) | Request a copy
	PDF (Surat Pernyataan Publikasi Karya Ilmiah) SURAT PERNYATAAN PUBLIKASI KARYA ILMIAH.pdf Restricted to Repository staff only Download (111kB) | Request a copy

Abstract

Indonesia ranks 4th in the world as the country with the highest number of Diabetes Melitus (DM) patien. This leads to increased use of antidiabetic. The existence of cost effectiveness analysis is required to assist the decision making process of effective antidiabetic selection in terms of costs. The purpose of this study was to compare the cost and effectiveness of antidiabetic use in patients with type II diabetes in outpatient installation of Caruban Madiun Hospital in 2016 using ACER and ICER method. This research is a non experimental study with retrospective time dimension without any treatment or intervention in patients at RSUD Caruban Madiun at 2016. DM patient data obtained from medical record installation and financial verification section. Data taken for this cost effectiveness analysis are data on the effectiveness of antidiabetic drug therapy and direct medical costs. The results of this study can be concluded that the most cost-effective antidiabetik is glimepirid with the value of ACER 67.935 and ICER value -13.529,92.

Item Type:	Karya ilmiah (Skripsi)
Uncontrolled Keywords:	Type II Diabetes Mellitus, cost effectiveness analysis, glimepiride, metformin
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Fakultas Farmasi > Farmasi
Depositing User:	MEGA KURNIA LAILY RAHMADHANI
Date Deposited:	09 Nov 2017 05:01
Last Modified:	09 Nov 2017 05:01
URI:	http://eprints.ums.ac.id/id/eprint/57441

Actions (login required)

View Item